PHLDA3
Pleckstrin homology-like domain family A member 3
Also known as: PHLA3_HUMAN, TIH1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y5J5
- Gene
- PHLDA3
- Ensembl
- ENSG00000174307
- Chromosome
- 1
- Canonical length
- 127 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables phosphatidylinositol phosphate binding activity and phosphatidylinositol-3,4-bisphosphate binding activity. Involved in intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; and positive regulation of apoptotic process. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
127 residues, UniProt reviewed canonical sequence.
>Q9Y5J5|PHLDA3
1 MTAAATATVL KEGVLEKRSG GLLQLWKRKR CVLTERGLQL FEAKGTGGRP KELSFARIKA
61 VECVESTGRH IYFTLVTEGG GEIDFRCPLE DPGWNAQITL GLVKFKNQQA IQTVRARQSL
121 GTGTLVSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PHLDA3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 145 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 145 nTPM
- colon: 131 nTPM
- breast: 114 nTPM
- spinal cord: 91 nTPM
- esophagus: 86 nTPM
- urinary bladder: 74 nTPM
Single-cell type
- late spermatids: 226 nCPM
- esophageal apical cells: 184 nCPM
- esophageal suprabasal cells: 179 nCPM
- epididymal basal cells: 173 nCPM
- ocular epithelial cells: 166 nCPM
- schwann cells: 161 nCPM
Immune cell
- neutrophil: 0.6 nTPM
- T-reg: 0.6 nTPM
- basophil: 0.3 nTPM
- classical monocyte: 0.1 nTPM
- gdT-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
Brain region
- medulla oblongata: 143 nTPM
- white matter: 127 nTPM
- pons: 97 nTPM
- thalamus: 97 nTPM
- cerebellum: 96 nTPM
- midbrain: 93 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0.25
- gnomAD missense Z
- 0.15
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure morphogenesis
- intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
- negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of apoptotic process
Molecular functions
- phosphatidylinositol-3,4,5-trisphosphate binding
- phosphatidylinositol-3,4-bisphosphate binding
- phosphatidylinositol-3,5-bisphosphate binding
- phosphatidylinositol-3-phosphate binding
- phosphatidylinositol-4,5-bisphosphate binding
- phosphatidylinositol-5-phosphate binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PHLDA3 as an antibody target. Whether an autoantibody or antibody against PHLDA3 could matter depends on whether native PHLDA3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PHLDA3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PHLDA3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...